Monthly Archives: January 2012

Antares Pharma Licenses A Drug Delivery Technology To Pfizer

January 10th, 2012|

Antares Pharma has recently announced that it has licensed to Pfizer Inc.’s Consumer Healthcare Business Unit one of its drug delivery technologies to develop an undisclosed product on an exclusive basis for North America. The companies did not disclose specifics of the deal.

Research partnership between Humana and Pfizer

January 4th, 2012|

Humana, one of the nation's largest health care companies, and Pfizer, the world's largest biopharmaceutical company, have recently linked together to explore new ideas and ways to improve the quality, outcomes and costs of the health care delivery system for senior citizens and other population.

Anti Measles Vaccination Drive

January 4th, 2012|

Every year large number of children die of measles, keeping this in mind the Centre has launched a massive anti-measles vaccination drive targeting 57 lakh children in the age group of 9 to 10 years. More than 13 crore children are expected to be covered under the Measles Catch-up Campaign, irrespective of their previous measles vaccination status.

Bat Plant can Fight Against Cancer

January 3rd, 2012|

A new study has been found by The University of Texas Health Science Center at San Antonio that Bat plant, or Tacca chantrieri, could be used to fight cancer.

FDA Warns Against Usage of Needle Free Flu Vaccine

January 3rd, 2012|

Recently, US Food and Drug Administration (FDA) has advised health providers not to use needle free injector devices to administer influenza vaccines, because so far no flu vaccines have been approved for administration using such devices, saying they are approved for only the measles, mumps and rubella vaccine.

Size of Indian Pharma Market

January 3rd, 2012|

Structure / Market Size The US Sector $ 12 billion valued pharmaceutical industry in India is expected to grow at an compound annual growth rate (CAGR) of 10-11 per cent. The industry spends around 18 per cent of its revenue on research and development (R&D).